Jazz Pharmaceuticals plc (JAZZ)
NASDAQ · Healthcare
Jazz Pharmaceuticals plc Long Term Debt 2009–2025
Jazz Pharmaceuticals plc annual long term debt history from 2012 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Jazz Pharmaceuticals plc long term debt as of December 31, 2025: 5.36B, a 12.28% decrease year-over-year.
- Jazz Pharmaceuticals plc long term debt for 2025 were 5.36B, a 12.28% decrease from 2024.
- Jazz Pharmaceuticals plc long term debt for 2024 were 6.11B, a 6.93% increase from 2023.
- Jazz Pharmaceuticals plc long term debt for 2023 were 5.71B, a 0.20% decrease from 2022.
- Jazz Pharmaceuticals plc long term debt for 2022 were 5.72B.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Jazz Pharmaceuticals plc Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $5,358 |
| 2024 | $6,109 |
| 2023 | $5,713 |
| 2022 | $5,724 |
| 2021 | $6,050 |
| 2020 | $2,095 |
| 2019 | $1,607 |
| 2018 | $1,596 |
| 2017 | $1,581 |
| 2016 | $2,030 |
| 2015 | $1,188 |
| 2014 | $1,342 |
| 2013 | $550 |
| 2012 | $427 |
Jazz Pharmaceuticals plc Long Term Debt — FAQ
Jazz Pharmaceuticals plc (JAZZ) long term debt over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see JAZZ's long term debt history?
The chart and table above show Jazz Pharmaceuticals plc's long term debt by year and by quarter, including the growth rate.